Skip to content

OraLiva

6 viewers · 30d

Total raised

$1.5M

1 filing since 2025 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $1.5M
ROUNDS
1
INVESTORS
1
FOUNDED
N/A
HQ
Durham, NC
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
6

AI overview

Updated

OraLiva, Inc. is an innovative medical technology company specializing in the development of advanced early detection diagnostics for oral cancer. By leveraging cutting-edge technology, the company aims to address the critical issue of late-stage cancer diagnosis, enhancing patient outcomes through timely intervention.

What sets it apart

OraLiva stands out for its clinically validated, AI-linked diagnostic platform that allows for noninvasive and rapid cancer detection directly at the point of care.

Funding history

1 round
SAFE+1Feb 14, 2025
Form D
+$1.5M$1.5M total

Latest SEC filings

via EDGAR · CIK 0001963569
Form D · Feb 14, 2025View on EDGAR

Products

1 tracked

ONC-InCyt Technology

Diagnostic Technology

The ONC-InCyt technology is a portable, programmable cytology platform designed for point-of-care use. This advanced diagnostic tool utilizes a microfluidic engine to process cells and deliver reliable diagnostics for oral cancer and oral dysplasia.

  • Noninvasive and painless procedure
  • High sensitivity and specificity in cancer detection
  • AI-linked diagnostic capabilities
  • Rapid results obtainable at the point of care

Links

WebsiteSEC EDGAR filings